Patent ID: 8236852

Claim:
A pharmaceutical composition for treating a subject suffering from an androgen receptor associated medical condition, comprising: a compound according to formula IIa or IIb: wherein: R 3 , R 4 , R 3 ′, and R 4 ′ are independently selected from the group consisting of —H, —OH, and —OCH 3 ; L is a carbonyl or L is an alkylene, or alkenylene, or alkynl when Z is not present; Z is selected from the group consisting of —H, —OH, a substituted styrenyl, or an aromatic ring, or a cycloalkyl, —COR 1 , or —CONR 1 R 2 , —CX 3 , wherein R 1 and R 2 are independently selected from the group consisting of —H, —CH 3 , and —C 2 H 5 or is not present; X is a halogen atom selected from the group consisting of —F, —Cl, and —Br; and further wherein the formula IIa and IIb are the equilibrate tautomers as a common phenomenon of diketone; further wherein said pharmaceutical composition treats said subject suffering from said androgen receptor associated medical condition.